We are live on ! Find out more
CDH

Charles D. Hyman Portfolio holdings

AUM $1.79B
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$871M
AUM Growth
+$65.6M
Cap. Flow
+$13.5M
Cap. Flow %
1.55%
Top 10 Hldgs %
31.91%
Holding
170
New
12
Increased
58
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$3.39M
2
INTC icon
Intel
INTC
+$1M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$938K
4
JPM icon
JPMorgan Chase
JPM
+$892K
5
MS.PRK icon
Morgan Stanley Series K Preferred Stock
MS.PRK
+$747K

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$1.82M
2
DIS icon
Walt Disney
DIS
+$544K
3
BMY icon
Bristol-Myers Squibb
BMY
+$535K
4
MMM icon
3M
MMM
+$512K
5
SCHW.PRB.CL
The Charles Schwab Corporation
SCHW.PRB.CL
+$305K

Sector Composition

Rank Sector Weight
1 Industrials 23.08%
2 Financials 11.55%
3 Consumer Staples 9.67%
4 Healthcare 8.92%
5 Technology 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDX icon
151
FedEx
FDX
$74.5B
$243K 0.03%
972
– –
FBNC icon
152
First Bancorp
FBNC
$2.6B
$224K 0.03%
6,349
– –
TTE icon
153
TotalEnergies
TTE
$193B
$221K 0.03%
4,000
– –
UPS icon
154
United Parcel Service
UPS
$97.6B
$220K 0.03%
1,844
– –
TGT icon
155
Target
TGT
$62.1B
$219K 0.03%
3,350
-450
-12% -$27.2K
EOG icon
156
EOG Resources
EOG
$78B
$216K 0.02%
+2,000
New +$201K
EXPE icon
157
Expedia Group
EXPE
$31.2B
$216K 0.02%
+1,800
New +$234K
EV
158
DELISTED
Eaton Vance Corp.
EV
$209K 0.02%
+3,700
New +$196K
BIIB icon
159
Biogen
BIIB
$29.9B
$207K 0.02%
+650
New +$209K
ETN icon
160
Eaton
ETN
$157B
$206K 0.02%
2,610
– –
AGN
161
DELISTED
Allergan plc
AGN
$206K 0.02%
+1,262
New +$226K
AMLP icon
162
Alerian MLP ETF
AMLP
$13B
$140K 0.02%
2,600
– –
NCV
163
Virtus Convertible & Income Fund
NCV
$374M
$94K 0.01%
3,350
– –
MTNB icon
164
Matinas BioPharma
MTNB
$1.55M
$93K 0.01%
1,596
– –
OPK icon
165
Opko Health
OPK
$921M
$89K 0.01%
18,119
– –
SMRT
166
DELISTED
Stein Mart Inc
SMRT
$45K 0.01%
38,900
– –
NVIV
167
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$23K ﹤0.01%
2
– –
GNMX
168
DELISTED
Aevi Genomic Medicine Inc
GNMX
$18K ﹤0.01%
15,143
– –
CVS icon
169
CVS Health
CVS
$137B
– –
-2,850
Closed -$232K
SCHW.PRB.CL
170
DELISTED
The Charles Schwab Corporation
SCHW.PRB.CL
– –
-12,000
Closed -$305K
3 4 5 6
7

Similar funds

AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Charles D. Hyman's Q4 2017 Portfolio in Review

As of Q4 2017, Charles D. Hyman held 170 positions worth $871M, up 8.2% from $805M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Charles D. Hyman's Q4 2017 filing shows 12 new, 58 increased, 39 reduced and 2 closed positions. Its largest new stake was Mastercard: 22,790 shares worth $3.45M. The largest sale was GE Aerospace, an estimated $1.82M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.

  • Charles D. Hyman's largest Q4 2017 buy was Mastercard: 22,790 shares worth $3.45M.
  • Charles D. Hyman added most to Intel in Q4 2017, an estimated $1M increase.
  • Charles D. Hyman's biggest Q4 2017 reduction was GE Aerospace, cutting an estimated $1.82M.
  • Charles D. Hyman fully exited The Charles Schwab Corporation in Q4 2017, selling an estimated $305K.
  • Charles D. Hyman's ten largest holdings make up 32% of its $871M portfolio in Q4 2017.
  • Charles D. Hyman opened 12 new positions and closed 2 in Q4 2017.
  • Charles D. Hyman's portfolio value rose 8.2% quarter-over-quarter to $871M.

Based on Charles D. Hyman's 13F filing for Q4 2017, filed 6 Feb 2018.